BIO-key International Inc. (NASDAQ:BKYI) Short Interest Down 22.0% in December

BIO-key International Inc. (NASDAQ:BKYIGet Free Report) saw a large decrease in short interest in December. As of December 31st, there was short interest totaling 108,223 shares, a decrease of 22.0% from the December 15th total of 138,814 shares. Based on an average daily trading volume, of 255,737 shares, the short-interest ratio is presently 0.4 days. Currently, 1.0% of the company’s stock are sold short. Currently, 1.0% of the company’s stock are sold short. Based on an average daily trading volume, of 255,737 shares, the short-interest ratio is presently 0.4 days.

Analyst Ratings Changes

BKYI has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, October 8th. Wall Street Zen raised shares of BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Get Our Latest Stock Report on BKYI

BIO-key International Trading Down 4.2%

Shares of NASDAQ:BKYI opened at $0.59 on Monday. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. BIO-key International has a 52-week low of $0.51 and a 52-week high of $2.14. The stock has a market cap of $6.42 million, a price-to-earnings ratio of -0.57 and a beta of 0.37. The business has a 50-day moving average price of $0.71 and a 200-day moving average price of $0.76.

BIO-key International (NASDAQ:BKYIGet Free Report) last issued its quarterly earnings results on Friday, November 14th. The technology company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.03). BIO-key International had a negative return on equity of 73.33% and a negative net margin of 70.23%.The business had revenue of $1.55 million during the quarter, compared to analyst estimates of $1.80 million.

BIO-key International Company Profile

(Get Free Report)

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.

Read More

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.